Cogstate (C4B) Stock Overview

A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. More details

C4B fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	5/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 41.4% below our estimate of its fair value

Earnings are forecast to grow 24.52% per year

Earnings grew by 46.7% over the past year

Risk Analysis

High level of non-cash earnings

C4B Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Cogstate Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cogstate
Historical stock prices
Current Share Price	AU$1.62
52 Week High	AU$1.67
52 Week Low	AU$1.41
Beta	0.13
1 Month Change	6.18%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	807.87%

Recent updates

Shareholder Returns

	C4B	DE Healthcare Services	DE Market
7D	7.4%	0.2%	-0.7%
1Y	n/a	17.2%	2.0%

Return vs Industry: Insufficient data to determine how C4B performed against the German Healthcare Services industry.

Return vs Market: Insufficient data to determine how C4B performed against the German Market.

Price Volatility

Is C4B's price volatile compared to industry and market?
C4B volatility
C4B Average Weekly Movement	5.7%
Healthcare Services Industry Average Movement	6.1%
Market Average Movement	6.0%
10% most volatile stocks in DE Market	13.1%
10% least volatile stocks in DE Market	2.8%

Stable Share Price: C4B has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine C4B's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	160	Brad O'Connor	www.cogstate.com

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments.

Cogstate Limited Fundamentals Summary

How do Cogstate's earnings and revenue compare to its market cap?
C4B fundamental statistics
Market cap	€283.62m
Earnings (TTM)	€9.31m
Revenue (TTM)	€48.46m

30.5x

P/E Ratio

5.9x

P/S Ratio

Is C4B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
C4B income statement (TTM)
Revenue	US$56.07m
Cost of Revenue	US$24.41m
Gross Profit	US$31.66m
Other Expenses	US$20.88m
Earnings	US$10.78m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Aug 18, 2026

Earnings per share (EPS)	0.063
Gross Margin	56.47%
Net Profit Margin	19.22%
Debt/Equity Ratio	0%

How did C4B perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

21%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/14 00:50
End of Day Share Price	2026/06/12 00:00
Earnings	2025/12/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cogstate Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Thomas Wakim	Bell Potter
Elyse Shapiro	Canaccord Genuity
Madeleine Williams	Canaccord Genuity

Cogstate LimitedDB:C4B Stock Report